Tyra Biosciences, Inc. (TYRA) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 1.37B USD. 52-week range 13.29 to 40.65 USD. Data as of 2026-10-09.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with ...